Project Grant R03DK138218

Award Date 7/15/24
Completion Date 6/30/26
Dollars Obligated $243K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $136,449 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the University of California, Berkeley (UC Berkeley) on December 1, 2024. The award supports research to evaluate the role of human obesity genes in specific neuronal populations using CRISPR-mediated gene downregulation in mice. The project aims to rapidly test whether genes associated with obesity are...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Arizona State University (ASU) a $1,040,519 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a 5-year research project to investigate the role of the protein JMJD3 in regulating leptin signaling and energy homeostasis in the hypothalamus. The project aims to: 1) Examine whether hypothalamic JMJD3 protects against obesity through an...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,539,044 to New York University School of Medicine to investigate the effects of obesity and diabetes on anti-viral immune responses. The researchers will use advanced techniques, including novel mouse models, bone marrow transplantation, and spatial transcriptomics, to...
This federal Project Grant award in the amount of $499,761 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, with a term from December 2024 to November 2029, will support research at the Albert Einstein College of Medicine to investigate a novel circuit linking hypothalamic neurons to neurons in the medial prefrontal cortex that regulate feeding...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $390,000 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Regents of the University of Michigan. The grant, awarded on June 20, 2024, will fund research to investigate the role of the inward rectifier potassium channel KIR7.1 in regulating energy homeostasis and its potential as a target for obesity treatments. The project aims to identify...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to understand how obesity-induced changes in the hematopoietic system contribute to inflammation and metabolic dysfunction. The $146,922 award, effective June 23, 2025 through March 14, 2025, will fund investigations into how inhibiting the migration of immature neutrophils...
This federal Project Grant award of $570,268.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research at the Albert Einstein College of Medicine to study the role of the Cyclin C (CCNC) protein in regulating adipose tissue remodeling and metabolic health. The key objectives of this research project are to investigate the cell-autonomous mechanisms by...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is providing $659,199 to the University of Pittsburgh to investigate a novel pathway by which the protein GDF15 produced by liver cells can improve insulin resistance associated with obesity, independent of GDF15's effects on body weight. The research aims to determine if endogenous GDF15 from...
This $176,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research at the University of Washington to investigate the role of hypothalamic microglia and perineuronal nets in obesity pathogenesis. The key objectives are to: 1) quantify how microglia regulate the turnover of perineuronal nets in the arcuate nucleus of the hypothalamus, 2)...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a five-year, $595,858 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Regents of the University of Michigan. The grant supports research to investigate the role of hypothalamic SH2B1 neurocircuits and SH2B1 signal transduction pathways in obesity and metabolic disease. Key objectives include determining whether the PVHSH2B1-DRN circuit mediates...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $242,848 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the New York Institute of Technology (NYIT) to support research on the role of the zinc finger protein 949 (ZFP949) as a potential regulator of adipocyte hypertrophy, a key characteristic of obesity. The research aims to leverage multi-omic approaches to identify the genes, proteins, and lipids that contribute to lipid accumulation in adipocytes, and determine if overexpressing ZFP949 could serve as a therapeutic target for obesity treatments. The award has an end date of June 30, 2026 and will enable NYIT to conduct this innovative study to advance the understanding of the cellular processes underlying obesity and identify potential new intervention strategies.

Generated 5/13/25, 3:53 AM